Etoricoxib Impurity A CAS 325855-74-1

$1 - 100 /Gram

Min. Order:

1 Gram

Contact Now

Product Description

Overview

Packaging & Delivery

Selling Units:: Gram

Etoricoxib is a highly selective cyclooxygenase-2 (COX-2) inhibitor developed by Merck. Etoricoxib has a unique chemical structure that is a methylsulfonyl group. The introduction of this group not only increases the The selectivity of the drug to COX-2 is improved, and there is no cross-allergic reaction with sulfonamide drugs. Etocoxib was first approved for listing in the UK in 2002, and subsequently listed in the European Union, Chemicalbook Asia Pacific, Australia and Latin America, etc. By the end of 2013, it had been approved for listing in 97 countries around the world, and is widely used in bone and joint applications. Treatment of many diseases such as osteoarthritis (OA), rheumatoid arthritis, ankylosing spondylitis, chronic low back pain, acute gouty arthritis, primary dysmenorrhea and postoperative pain. Etoricoxib has also been listed in Taiwan and Hong Kong, and was launched in mainland China in 2008. The approved indications are acute gouty arthritis and OA. In the second half of 2014, it was approved for primary dysmenorrhea indications.

Product Categories : API Intermediates > Etoricoxib Intermediate

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Lily
*Email:
*Message:

Your message must be between 20-8000 characters